A carregar...
Uptake of Oxaliplatin and Bevacizumab for Treatment of Node-Positive and Metastatic Colon Cancer
PURPOSE: In 2004, the US Food and Drug Administration approved bevacizumab and oxaliplatin for use in metastatic colon cancer and oxaliplatin for localized colon cancer. We investigated the diffusion and predictors of use of these medications in the year after approval. PATIENTS AND METHODS: We used...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Clinical Oncology
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3396803/ https://ncbi.nlm.nih.gov/pubmed/22942809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2011.000371 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|